Hormones play an integral role in health and wellness. They promote growth within the body and influence metabolism, organ function, energy, and weight management. There are many factors that can interfere with hormone production, including aging. As people age, their body may not produce adequate levels of hormones.
Sermorelin, a growth hormone releasing hormone (GHRH), can enhance overall health and wellbeing by stimulating the production and release of hormones by the pituitary gland.
Sermorelin is a bioidentical synthetic hormone peptide that contains 29 amino acids and may be used in conjunction with bioidentical hormone replacement therapy (BHRT), weight loss programs, and erectile dysfunction treatment.
Sermorelin* and Sermorelin/Peptide blends have been known to support a variety of functions related to growth hormone levels and may:
Quality of sleep
Recovery from workouts
Sermorelin can be used alone or in combination with growth hormone replacing peptides (GHRP) such as GHRP(2) and GHRP(6). Theanine may be used as well.
Secretropin is the first clinically proven natural stimulator of growth hormone production, and is gaining the medical community's acceptance as a more desirable "first step" approach to pursuing hormonal balance.
Developed in 2001, the product virtually sat on the shelf due to the availability of recombinant human growth hormone (rhGH). Between 2001 and 2006, the product was sold quietly to patients that preferred not to pay the high price of rhGH. Secretropin received early medical acknowledgment for its reproducible effectiveness and its preferable oral delivery. In as little as 4 weeks Secretropin has been shown to increase the production of human growth hormone by 50 - 200% while being delivered as an oral spray. Secretropin's oral delivery system owes its effectiveness to the latest nanoliposomal technology, which wraps the active agents in a protective envelope. Until this delivery technology was available, stomach acid would inactivate and destroy the active agents responsible for the increase in growth hormone production.
Prior to Secretropin, the injectable growth hormone was the only viable option for increasing human growth hormone. Fortunately, the nanoliposomal technology protects the complex, allowing for optimal absorption and leading to a more natural increase in growth hormone levels—thus eliminating the less desirable approach of daily injections.
In October 2006, an initial study group of 50 individuals was employed for a prospective, 12-month study on the product's efficacy on increasing IGF-1 and IGFBP-3 levels. As this study approached completion in January 2008, a subsequent study design was begun to include multiple centers for a continued long term assessment of the product's efficacy. We anticipate employing hundreds of new patients. It is the goal of these studies to constantly show the efficacy and related benefits from an amino acid complex growth hormone stimulator.